-9
NPS Score
VS
Sarepta Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 34
- TOTAL
RATINGS
Ultragenyx Pharmaceutical Claimed Company
- EMPLOYEE
PARTICIPANTS - 20
- TOTAL
RATINGS
Sarepta Therapeutics vs Ultragenyx Pharmaceutical
Compare Sarepta Therapeutics versus Ultragenyx Pharmaceutical for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 34 employees and customers of Sarepta Therapeutics and 20 employees and customers of Ultragenyx Pharmaceutical.
Sarepta Therapeutics
Sarepta Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Sarepta Therapeutics. Their current market cap is $11.66B.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Ultragenyx Pharmaceutical. Their current market cap is $3.64B.
3.7/5
Product Quality
4/5
3.7/5
Pricing
3.9/5
5/5
Customer Service
3.8/5
| 36% | Promoters |
|---|---|
| 19% | Passive |
| 45% | Detractors |
31
NPS Score
| 50% | Promoters |
|---|---|
| 31% | Passive |
| 19% | Detractors |
Net Promoter Score
Winner by 40
See how Sarepta Therapeutics compares to its competitors
See how Ultragenyx Pharmaceutical compares to its competitors
Working at Sarepta Therapeutics vs Working at Ultragenyx Pharmaceutical
79 / 100
CEO Rating
86 / 100
CEO Rating
Winner by 7%
Sarepta Therapeutics
Sarepta Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Ultragenyx Pharmaceutical
Employees at Ultragenyx Pharmaceutical rate their CEO, Emil Kakkis, 86/100. This score is 7% higher than the scores of Sarepta Therapeutics' CEO, Douglas Ingram.